Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Immuno-oncology: manufacturing and commercial business models for the new decade

GUEST EDITOR: Dr Usman Azam, President & CEO, Tmunity Therapeutics Inc
  • Analysing early commercial experiences with cellular immunotherapies – what lessons for the next generation of product candidates making the transition from clinical to commercial? (Eg. in terms of cost control? Market and patient access strategies?)
  • Enabling allogeneic approaches
    • Are iPSCs ready to step forward? What are developers’, manufacturers’ and regulators’ key concerns?
  • Cell transduction/engineering tools and techniques – what does the future hold for viral and non-viral vectors and gene editing?
  • How will decentralised manufacturing models continue to evolve and emerge?
  • Global supply chain optimisation
COMING IN JUNE 2020
Twitter IconVisit Our Blog